Large-scale testing (Phase 3)Study completedNCT02017340What this trial is testingA Phase III Trial of Nilvadipine to Treat Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Prof Brian Lawlor 511
Large-scale testing (Phase 3)Ended earlyNCT00550420What this trial is testingStudy Of Rosiglitazone XR In Subjects With Mild-to-Moderate AlzheimersWho this might be right forAlzheimer's Disease GlaxoSmithKline 331
Testing effectiveness (Phase 2)Study completedNCT00141661What this trial is testingA Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's PatientsWho this might be right forAlzheimer Disease Pfizer 67
Post-approval studies (Phase 4)Study completedNCT00202124What this trial is testingDouble Blind Study of Trp01 in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Queen's University 12
Not applicableUnknownNCT04495686What this trial is testingAn Innovative Supportive Care Model for Dementia and Traumatic Brain InjuryWho this might be right forDementia, MixedDementia MildDementia Moderate+2 more University of Virginia 171
Not applicableLooking for participantsNCT04124029What this trial is testingContributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)Who this might be right forMild Traumatic Brain InjuryModerate Traumatic Brain InjuryMild Cognitive Impairment VA Office of Research and Development 800
Testing effectiveness (Phase 2)Study completedNCT00093951What this trial is testingSGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)Who this might be right forAlzheimer's Disease Saegis Pharmaceuticals 280
Testing effectiveness (Phase 2)Study completedNCT02249403What this trial is testingEfficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer TypeWho this might be right forAlzheimer Disease Boehringer Ingelheim 362
Testing effectiveness (Phase 2)Study completedNCT01354691What this trial is testingSafety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's DiseaseWho this might be right forAlzheimer's DiseaseDementiaMemory Loss+1 more Avraham Pharmaceuticals Ltd 200
Testing effectiveness (Phase 2)UnknownNCT05578443What this trial is testingEfficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Fujian Medical University Union Hospital 66
Large-scale testing (Phase 3)Ended earlyNCT00857649What this trial is testingEfficacy and Safety of Memantine in Moderate to Severe Alzheimer's DiseaseWho this might be right forAlzheimer's Disease H. Lundbeck A/S 369
Large-scale testing (Phase 3)Looking for participantsNCT04570085What this trial is testingEffect of CAFfeine on Cognition in Alzheimer's DiseaseWho this might be right forAlzheimer Disease University Hospital, Lille 248
Not applicableTemporarily pausedNCT03484143What this trial is testingNeuro RX Gamma - Pivotal PhaseWho this might be right forAlzheimer Disease Vielight Inc. 228
Testing effectiveness (Phase 2)UnknownNCT00606164What this trial is testingSafety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Blanchette Rockefeller Neurosciences Insitute 9
Testing effectiveness (Phase 2)Study completedNCT01723826What this trial is testingA Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With CrenezumabWho this might be right forAlzheimer's Disease Genentech, Inc. 360
Testing effectiveness (Phase 2)Study completedNCT02756858What this trial is testingAn Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Anavex Life Sciences Corp. 21
Not applicableLooking for participantsNCT05295615What this trial is testingPulsed Electromagnetic Field Treatment In Patients With Alzheimer's DiseaseWho this might be right forAlzheimer Disease Herrick Medical LLC 40
Early research (Phase 1)Study completedNCT02353598What this trial is testingCrenezumab in Participants With Mild to Moderate Alzheimer DiseaseWho this might be right forAlzheimer Disease Genentech, Inc. 77
Testing effectiveness (Phase 2)Study completedNCT02947893What this trial is testingImpact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Georgetown University 37
Testing effectiveness (Phase 2)Study completedNCT05363293What this trial is testingMultiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult SubjectsWho this might be right forAlzheimer's DiseaseHealthy Non-elderly and Elderly Adults Alzamend Neuro, Inc. 65